Santhera Pharmaceuticals Holding AG SPHDF
Set alert
18.30 USD 0.00 0.00%
At close · Oct 30
22.85 Day range 22.85
12.28 52-week range 23.25
- YTD
- +37.08%
- 1 year
- +49.14%
- Open
- 22.85
- Prev close
- 18.30
- Mkt cap
- 280.34M
- Vol
- 100
- Avg vol
- 10
- EPS
- -2.82
- P/E
- 0.00
More statistics
- Low
- 22.85
- High
- 22.85
2Y chart
Signals (30)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 9, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| RSI: Oversold | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | May 11, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 16, 2026 | 6 months ago |
| RSI: Overbought | Apr 16, 2026 | 6 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| SMA: Bearish | Mar 24, 2026 | 7 months ago |
| RSI: Overbought | Mar 11, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 21, 2026 | 9 months ago |
| RSI: Overbought | Jan 21, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 19, 2025 | 10 months ago |
| SMA: Bullish | Dec 2, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| SMA: Bearish | Sep 29, 2025 | 1 year ago |
| RSI: Oversold | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 15, 2025 | 1 year ago |
| SMA: Bullish | Jul 28, 2025 | 1 year ago |
| RSI: Overbought | Jul 28, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 17, 2025 | 1 year ago |
| SMA: Bearish | May 27, 2025 | 1 year ago |
| RSI: Oversold | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| RSI: Overbought | Mar 11, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 23, 2024 | 1 year ago |
News
- Santhera Pharmaceuticals Holding AG (SPHDF) Q2 2026 Earnings Call Transcript
- Santhera nears cash break-even as AGAMREE gains traction, Edison says
- Santhera Pharmaceuticals Holding AG (SPHDF) Q4 2025 Earnings Call Transcript
- eBay heads into Q1 earnings with momentum, but macro clouds loom
- Santhera reconfirms cash flow breakeven target as AGAMREE revenues near-double
- Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025
- Santhera wins backing to extend DMD drug AGAMREE to toddlers as young as two
- Santhera Pharmaceuticals (OTCMKTS:SPHDF) Trading Up 35.4% – What’s Next?
- Santhera Pharmaceuticals: Delivers life-changing treatment to little fanfare. Soon the numbers will support its progress
- BlackRock shares jump on Q4 earnings, record $14T assets under management
Your note
Sign in to keep a note on SPHDF — it syncs with the Stock Master app.